Artificial Coma/Medically Induced Coma Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067513
  • January 2022
  • Medical Devices
  • 125 Pages
Report Description

This report is a comprehensive study that examines the Artificial Coma/Medically Induced Coma industry in depth. With reference to key regions and major nations, the study specifies the product type of Artificial Coma/Medically Induced Coma as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Artificial Coma/Medically Induced Coma market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Artificial Coma/Medically Induced Coma market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Artificial Coma/Medically Induced Coma market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Artificial Coma/Medically Induced Coma Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Artificial Coma/Medically Induced Coma market study. The market dynamics and factors such as the threat of a Artificial Coma/Medically Induced Coma substitute, the threat of new entrants into the Artificial Coma/Medically Induced Coma market, buyer bargaining power, supplier bargaining power to Artificial Coma/Medically Induced Coma providing companies, and internal rivalry among Artificial Coma/Medically Induced Coma providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Artificial Coma/Medically Induced Coma market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Artificial Coma/Medically Induced Coma industry.
 
Artificial Coma/Medically Induced Coma Market Key Trends Analysis

The important factors influencing the growth of the Artificial Coma/Medically Induced Coma market have been examined in this report. The driving factors that are boosting demand for Artificial Coma/Medically Induced Comas and the restraining factors that are slowing growth of the Artificial Coma/Medically Induced Coma industry are addressed in depth, as well as their implications for the worldwide Artificial Coma/Medically Induced Coma market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Artificial Coma/Medically Induced Coma Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Artificial Coma/Medically Induced Coma industry. On the basis of current and future trends, all segments of the Artificial Coma/Medically Induced Coma industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Artificial Coma/Medically Induced Coma Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Artificial Coma/Medically Induced Coma market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Artificial Coma/Medically Induced Coma market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Artificial Coma/Medically Induced Coma market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Artificial Coma/Medically Induced Coma market. All important stakeholders in the Artificial Coma/Medically Induced Coma value chain and technological ecosystem are expected to benefit from the insights offered in the Artificial Coma/Medically Induced Coma market research study.

In order to provide a broader understanding of the top competitors in the Artificial Coma/Medically Induced Coma market, the research includes a company market share analysis. Astrazeneca Plc., B. Braun Melsungen, Baxter Healthcare Corporation, Dr.Reddy\'s Laboratories, Fresenious SE & CO., Hikma Pharmaceuticals, Pfizer Inc., Piramal Healthcare, Teva Pharmaceuticals Industries Ltd., Viatris Inc. are among the major participants in the global Artificial Coma/Medically Induced Coma industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Astrazeneca Plc., B. Braun Melsungen, Baxter Healthcare Corporation, Dr.Reddy\'s Laboratories, Fresenious SE & CO., Hikma Pharmaceuticals, Pfizer Inc., Piramal Healthcare, Teva Pharmaceuticals Industries Ltd., Viatris Inc.
 
Major Highlights of the Artificial Coma/Medically Induced Coma Market report study:
  • An in-depth examination of the global Artificial Coma/Medically Induced Coma industry will be published soon.
  • The study examines the global Artificial Coma/Medically Induced Coma market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Artificial Coma/Medically Induced Coma industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Artificial Coma/Medically Induced Coma market is being shaped by several major trends.
  • The size of the Artificial Coma/Medically Induced Coma market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Artificial Coma/Medically Induced Coma market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Artificial Coma/Medically Induced Coma market as follows:
Global Artificial Coma/Medically Induced Coma Market: By Product Type

  • Propofol
  • Barbiturate

Global Artificial Coma/Medically Induced Coma Market: By Application
  • Status Epilepticus
  • Stroke
  • Traumatic Brain Injury
  • Brain Infections
  • Drug Overdose
  • Others

Global Artificial Coma/Medically Induced Coma Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Artificial Coma/Medically Induced Coma market.
  • Universities and students
  • Other companies in the Artificial Coma/Medically Induced Coma market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Artificial Coma/Medically Induced Coma market

Manufacturers and Segments

  • Astrazeneca Plc.
  • B. Braun Melsungen
  • Baxter Healthcare Corporation
  • Dr.Reddy's Laboratories
  • Fresenious SE & CO.
  • Hikma Pharmaceuticals
  • Pfizer Inc.
  • Piramal Healthcare
  • Teva Pharmaceuticals Industries Ltd.
  • Viatris Inc.
  • Propofol
  • Barbiturate
  • Status Epilepticus
  • Stroke
  • Traumatic Brain Injury
  • Brain Infections
  • Drug Overdose
  • Others

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Artificial Coma/Medically Induced Coma Market Snapshot
          2.1.1. Global Artificial Coma/Medically Induced Coma Market By Propofol,2019
               2.1.1.1.
               2.1.1.2.Propofol
          2.1.2. Global Artificial Coma/Medically Induced Coma Market By Status Epilepticus,2019
               2.1.2.1.
               2.1.2.2.Status Epilepticus
               2.1.2.3.Stroke
               2.1.2.4.Traumatic Brain Injury
               2.1.2.5.Brain Infections
               2.1.2.6.Drug Overdose
          2.1.3. Global Artificial Coma/Medically Induced Coma Market By End-use,2019
          2.1.4. Global Artificial Coma/Medically Induced Coma Market By Geography,2019

3. Global Artificial Coma/Medically Induced Coma Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Propofol, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Propofol, 2020
     4.2. Global Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028

5. Global Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Status Epilepticus, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Status Epilepticus, 2020
     5.2. Global Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028

6. Global Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028

7. Global Artificial Coma/Medically Induced Coma Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Artificial Coma/Medically Induced Coma Market Analysis, 2018 – 2028 
          7.2.1. North America Artificial Coma/Medically Induced Coma Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028
          7.2.3. North America Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028
          7.2.4. North America Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Artificial Coma/Medically Induced Coma Market Analysis, 2018 – 2028 
          7.3.1.  Europe Artificial Coma/Medically Induced Coma Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028
          7.3.3. Europe Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028
          7.3.4. Europe Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Artificial Coma/Medically Induced Coma Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Artificial Coma/Medically Induced Coma Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028
          7.4.3. Asia Pacific Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028
          7.4.4. Asia Pacific Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Artificial Coma/Medically Induced Coma Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Artificial Coma/Medically Induced Coma Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028
          7.5.3. Latin America Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028
          7.5.4. Latin America Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Artificial Coma/Medically Induced Coma Market Analysis, 2018 – 2028 
          7.6.1.  MEA Artificial Coma/Medically Induced Coma Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Artificial Coma/Medically Induced Coma Market Size (US$), By Propofol, 2018 – 2028
          7.6.3. MEA Artificial Coma/Medically Induced Coma Market Size (US$), By Status Epilepticus, 2018 – 2028
          7.6.4. MEA Artificial Coma/Medically Induced Coma Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Artificial Coma/Medically Induced Coma Providers
        8.4.1 Astrazeneca Plc.
                8.4.1.1 Business Description
                8.4.1.2 Astrazeneca Plc. Geographic Operations
                8.4.1.3 Astrazeneca Plc. Financial Information
                8.4.1.4 Astrazeneca Plc. Product Positions/Portfolio
                8.4.1.5 Astrazeneca Plc. Key Developments
        8.4.2 B. Braun Melsungen
                8.4.2.1 Business Description
                8.4.2.2 B. Braun Melsungen Geographic Operations
                8.4.2.3 B. Braun Melsungen Financial Information
                8.4.2.4 B. Braun Melsungen Product Positions/Portfolio
                8.4.2.5 B. Braun Melsungen Key Developments
        8.4.3 Baxter Healthcare Corporation
                8.4.3.1 Business Description
                8.4.3.2 Baxter Healthcare Corporation Geographic Operations
                8.4.3.3 Baxter Healthcare Corporation Financial Information
                8.4.3.4 Baxter Healthcare Corporation Product Positions/Portfolio
                8.4.3.5 Baxter Healthcare Corporation Key Developments
        8.4.4 Dr.Reddy's Laboratories
                8.4.4.1 Business Description
                8.4.4.2 Dr.Reddy's Laboratories Geographic Operations
                8.4.4.3 Dr.Reddy's Laboratories Financial Information
                8.4.4.4 Dr.Reddy's Laboratories Product Positions/Portfolio
                8.4.4.5 Dr.Reddy's Laboratories Key Developments
        8.4.5 Fresenious SE & CO.
                8.4.5.1 Business Description
                8.4.5.2 Fresenious SE & CO. Geographic Operations
                8.4.5.3 Fresenious SE & CO. Financial Information
                8.4.5.4 Fresenious SE & CO. Product Positions/Portfolio
                8.4.5.5 Fresenious SE & CO. Key Developments
        8.4.6 Hikma Pharmaceuticals
                8.4.6.1 Business Description
                8.4.6.2 Hikma Pharmaceuticals Geographic Operations
                8.4.6.3 Hikma Pharmaceuticals Financial Information
                8.4.6.4 Hikma Pharmaceuticals Product Positions/Portfolio
                8.4.6.5 Hikma Pharmaceuticals Key Developments
        8.4.7 Pfizer Inc.
                8.4.7.1 Business Description
                8.4.7.2 Pfizer Inc. Geographic Operations
                8.4.7.3 Pfizer Inc. Financial Information
                8.4.7.4 Pfizer Inc. Product Positions/Portfolio
                8.4.7.5 Pfizer Inc. Key Developments
        8.4.8 Piramal Healthcare
                8.4.8.1 Business Description
                8.4.8.2 Piramal Healthcare Geographic Operations
                8.4.8.3 Piramal Healthcare Financial Information
                8.4.8.4 Piramal Healthcare Product Positions/Portfolio
                8.4.8.5 Piramal Healthcare Key Developments
        8.4.9 Teva Pharmaceuticals Industries Ltd.
                8.4.9.1 Business Description
                8.4.9.2 Teva Pharmaceuticals Industries Ltd. Geographic Operations
                8.4.9.3 Teva Pharmaceuticals Industries Ltd. Financial Information
                8.4.9.4 Teva Pharmaceuticals Industries Ltd. Product Positions/Portfolio
                8.4.9.5 Teva Pharmaceuticals Industries Ltd. Key Developments
        8.4.10 Viatris Inc.
                8.4.10.1 Business Description
                8.4.10.2 Viatris Inc. Geographic Operations
                8.4.10.3 Viatris Inc. Financial Information
                8.4.10.4 Viatris Inc. Product Positions/Portfolio
                8.4.10.5 Viatris Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Artificial Coma/Medically Induced Coma Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Artificial Coma/Medically Induced Coma Market Revenue, By Propofol, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Artificial Coma/Medically Induced Coma Market Revenue, By Status Epilepticus, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Artificial Coma/Medically Induced Coma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Artificial Coma/Medically Induced Coma Market Revenue, By Propofol, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Artificial Coma/Medically Induced Coma Market Revenue, By Status Epilepticus, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Artificial Coma/Medically Induced Coma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Artificial Coma/Medically Induced Coma Market Revenue, By Propofol, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Artificial Coma/Medically Induced Coma Market Revenue, By Status Epilepticus, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Artificial Coma/Medically Induced Coma Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Artificial Coma/Medically Induced Coma Market Revenue, By Propofol, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Artificial Coma/Medically Induced Coma Market Revenue, By Status Epilepticus, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Artificial Coma/Medically Induced Coma Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Artificial Coma/Medically Induced Coma Market Revenue, By Propofol, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Artificial Coma/Medically Induced Coma Market Revenue, By Status Epilepticus, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Artificial Coma/Medically Induced Coma Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Artificial Coma/Medically Induced Coma: Market Segmentation 
FIG. 2 Global Artificial Coma/Medically Induced Coma Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Artificial Coma/Medically Induced Coma Market, By Propofol, 2019 (US$ Mn) 
FIG. 5 Global Artificial Coma/Medically Induced Coma Market, By Status Epilepticus, 2019 (US$ Mn) 
FIG. 6 Global Artificial Coma/Medically Induced Coma Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Artificial Coma/Medically Induced Coma Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Artificial Coma/Medically Induced Coma Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Artificial Coma/Medically Induced Coma Providers, 2019
FIG. 11 Global Artificial Coma/Medically Induced Coma Market Revenue Contribution, By Propofol, 2019 & 2028 (Value %) 
FIG. 12 Global Artificial Coma/Medically Induced Coma Market Revenue Contribution, By Status Epilepticus, 2019 & 2028 (Value %) 
FIG. 13 Global Artificial Coma/Medically Induced Coma Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Artificial Coma/Medically Induced Coma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Artificial Coma/Medically Induced Coma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Artificial Coma/Medically Induced Coma Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Artificial Coma/Medically Induced Coma Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Artificial Coma/Medically Induced Coma Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Artificial Coma/Medically Induced Coma market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Artificial Coma/Medically Induced Coma Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Artificial Coma/Medically Induced Coma Market Value, By Segment1, 2018 – 2028
TABLE  North America Artificial Coma/Medically Induced Coma Market Value, By Segment2, 2018 – 2028
TABLE  North America Artificial Coma/Medically Induced Coma Market Value, By Country, 2018 – 2028
TABLE  Europe Artificial Coma/Medically Induced Coma Market Value, By Segment1, 2018 – 2028
TABLE  Europe Artificial Coma/Medically Induced Coma Market Value, By Segment2, 2018 – 2028
TABLE  Europe Artificial Coma/Medically Induced Coma Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Artificial Coma/Medically Induced Coma Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Artificial Coma/Medically Induced Coma Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Artificial Coma/Medically Induced Coma Market Value, By Country, 2018 – 2028
TABLE  Latin America Artificial Coma/Medically Induced Coma Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Artificial Coma/Medically Induced Coma Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Artificial Coma/Medically Induced Coma Market Value, By Country, 2018 – 2028
TABLE  MEA Artificial Coma/Medically Induced Coma Market Value, By Segment1, 2018 – 2028
TABLE  MEA Artificial Coma/Medically Induced Coma Market Value, By Segment2, 2018 – 2028
TABLE  MEA Artificial Coma/Medically Induced Coma Market Value, By Country, 2018 – 2028
TABLE  Astrazeneca Plc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  B. Braun Melsungen: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Baxter Healthcare Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dr.Reddy's Laboratories: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Fresenious SE & CO.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hikma Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pfizer Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Piramal Healthcare: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceuticals Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Viatris Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Artificial Coma/Medically Induced Coma Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Artificial Coma/Medically Induced Coma Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Artificial Coma/Medically Induced Coma Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Artificial Coma/Medically Induced Coma Market, By Geography, 2019 (US$ Mn)
FIG.  Global Artificial Coma/Medically Induced Coma Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Artificial Coma/Medically Induced Coma Providers, 2016
FIG.  Global Artificial Coma/Medically Induced Coma Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Propofol Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Barbiturate Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Artificial Coma/Medically Induced Coma Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Status Epilepticus Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Stroke Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Traumatic Brain Injury Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Brain Infections Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Drug Overdose Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Artificial Coma/Medically Induced Coma Market Value, 2018 – 2028, (US$ Mn)